A recent study on T cell gene therapy trials shows that while secondary malignancies occur in a small percentage of patients, ...

MeiraGTx's innovative gene therapies for ocular diseases & more are backed by strong clinical data and funding. Click here to find out why MGTX stock is a Buy.

Giulio Cossu, MD, speaks to the lingering safety concerns related to ex vivo gene therapy in Duchenne muscular dystrophy (DMD) as long-term data are yet to be established.

Multi-year partnership will help 10,000+ customers securely build and deploy AI agents with Claude over their enterprise data SAN FRANCISCO, March 26, 2025 /PRNewswire/ -- Databricks, the ...

At first glance, this seems like a win for transparency. If an AI explains itself, we can understand its motives, catch ...

Looking for pest control in San Diego? Orkin, Terminix and Western Exterminator Company are our top picks. Compare services, reviews, costs and more.

Danon disease is a rare but serious cardiomyopathy that drastically reduces life expectancy. Male patients infrequently live ...

Carlyle Group's acquisition of bluebird bio for $3 per share offers a potential but unlikely $600 million sales milestone by ...

Java 24 is a feature release, meaning that Oracle will support it for six months. Its successor, Java 25, is due in September and will be supported for eight years as an LTS (long-term support) ...

Why Norstella, Makersite, Satelytics, and Chainalysis are among Fast Company's Most Innovative Companies in data science for ...

The construction industry continued to see either growth or stability in all its sectors in 2024. Anchored by a large thrust ...

AstraZeneca will acquire all outstanding equity of EsoBiotec for a total consideration of up to $1,000m, on a cash and debt free basis. This will include an initial payment of $425m on deal closing, ...